IRCT201108254166N4
Completed
未知
Intraocular pressure lowering effect of Lataprost eye drop with once every other day dosing
Tabriz University of MedicalSciences0 sites50 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Glaucoma.
- Sponsor
- Tabriz University of MedicalSciences
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria: 1\. Administering eye drop Lataprost % one time at night 2\. At least two prior IOP checking in recent month 3\. Appropriate IOP control with present medications 4\. No prior intraocular surgery
- •Exclusion criteria: 1\. Glaucoma surgery 2\. Incomplete response to 2 antiglaucoma 3\. Not possible to follow\-up 4\. Corneal problem that interferes with IOP checking 5\. Ocular problem except cataract \& glaucoma
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomyPatients with open-angle glaucoma after trabeculectomyJPRN-UMIN000000893Kumamoto University60
Completed
Phase 2
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGOcular HypertensionOpen-Angle GlaucomaNCT01037036Mati Therapeutics Inc.15
Completed
Phase 4
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.GlaucomaOcular HypertensionNCT00143208Pfizer's Upjohn has merged with Mylan to form Viatris Inc.250
Completed
Phase 4
Effect of latanoprost and travoprost ophthalmic solution on corneal epitheliumglaucomaJPRN-UMIN000004000Department of Ophtalmology, University of Tokyo80
Not yet recruiting
Not Applicable
Effect of pressure reducing effect of Ripasudil eye drops in patients with high pressure within the eyeHealth Condition 1: H401- Open-angle glaucomaCTRI/2022/09/045191Sankara eye hospital